McDermott + Bull has successfully placed Garlan Adams as the General Counsel at Crinetics Pharmaceuticals. Garlan will bring a proactive approach to the management of the legal and compliance efforts of the company. She will serve as a thought partner to the Chief Executive Officer and leadership team as the company approaches commercialization.

Garlan brings over 20 years of legal leadership experience in clinical and commercial pharmaceutical and biotechnology businesses. Most recently, Garlan served as the Special Advisor, Integrity and Compliance at Indivior. Prior to Indivior, she was the Vice President, General Counsel at Avanir Pharmaceuticals. Garlan’s expertise will be influential in the company’s continued growth and evolution.

Crinetics is a clinical-stage, publicly traded pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

This executive search was completed by McDermott + Bull Managing Partner Craig Lipus, Partner Garrett Lipus, and Directors Tim Dotson and Brian Selvey.